Navigation Links
Pharmaceutical Pricing and Health Outcomes Top Trending News This Week from HealthEconomics.Com
Date:5/29/2013

Ponte Vedra Beach, FL (PRWEB) May 29, 2013

This week’s top news story on HealthEconomics.Com covered newly released survey results on Payer Strategies for Emerging Markets, conducted by Hanson Wade, based on interviews with Pharma/Biotech/Medical Device companies, Consulting companies, Academia, Regulators, and Providers. There was universal consensus among the respondents that, by 2018, more than one-third of pharmaceutical company revenues will come from emerging markets, including Brazil, Russia, Asia/Pac, Africa, among others. The greatest barrier to pharma growth in emerging markets was weak industry-payer partnerships (33% of respondents), followed by lack of out-of-pocket payer engagement (22%) and competition from generics (22%). Diabetes was thought to be the biggest potential therapeutic area, while Saudia Arabia followed by Nigeria were two countries of focus after BRIC TM (Brazil, Russia, India, China, Turkey, and Mexico) emerging markets. This story was sourced from Hanson Wade Limited.

The second most read story on HealthEconomics.Com was derived from an abstract by Dr. Gary Lyman, of Duke University and the Duke Cancer Institute in Durham, North Carolina, published in The Oncologist journal on May 22, 2013 discussing comparative effectiveness research (CER) in oncology. Oncology is a therapeutic area that is uniquely positioned to utilize CER to inform appropriate and optimal patient care, particularly among high-cost interventions. The author posits that the development and evaluation of genomic and other personalized medicine approaches poses significant challenges for CER in oncology. Lyman has written on this subject in other journals, including the Journal of Clinical Oncology.

Another popular news item on HealthEconomics.Com covered the latest addition to the HE-Artist series with a profile of Sean Sullivan, PhD, Professor and Associate Dean for Research at the University of Washington School of Pharmacy who is also a drummer and plays in a band of health economists called The Monte Carlos. Dr. Sullivan’s passion for drumming, coupled with his many contributions to the field of health economics and health policy, are featured in HE-Artists on HealthEconomics.Com.

About HealthEconomics.Com (http://www.healtheconomics.com):
A pioneer in the field, HealthEconomics.Com is the global authority in healthcare value and pharma market access. Each day, HealthEconomics.Com compiles the latest news, policy updates, resources, conferences, and jobs for BioPharma’s professionals involved in health economics, outcomes research, market access, and pricing. A trusted resource, HealthEconomics.Com’s comprehensive content is carefully selected by a discerning health economist editor, making it the most visited website for healthcare value and market access in the industry, with visitors encompassing all corners of the globe.

News Media interested in receiving the most current information on healthcare value and market access may obtain a free subscription to HealthEconomics.Com by visiting the site or by subscribing to the HealthEconomics.Com Newsletter.

Read the full story at http://www.prweb.com/releases/HealthEconomicsCom/TopNews/prweb10778875.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Global, common approach to pharmaceutical supply chain integrity the focus of workshop
2. MSU invention could help pharmaceutical industry save money
3. Nobel laureate to keynote international pharmaceutical conference at URI
4. 5 more pharmaceutical companies join NIH initiative to speed therapeutic discovery
5. Is it constitutional for states to regulate pharmaceutical gifts and meals to doctors?
6. Pharmica Consulting to Hold HIT Conference for the Pharmaceutical Industry
7. Scientists use sound waves to levitate liquids, improve pharmaceuticals
8. Medical care presents update on pharmaceutical health services research
9. Taiho Pharmaceutical unveils data on 8 novel anticancer compounds
10. Environmentally friendly chemistry important for manufacturing pharmaceuticals
11. Edison Pharmaceuticals announces initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... FL (PRWEB) , ... May 06, 2016 , ... ... will feature AsedaSciences® in an upcoming episode, airing third quarter 2016, via Discovery ... the vision of becoming a leader in optimized drug discovery through innovative cellular ...
(Date:5/6/2016)... ... , ... Online HR/benefits platforms offer a range of benefits functions to employers ... health plans. “ The Rapid Emergence of Online Benefits Firms: Strategies for Health Plans ... will offer an accurate picture of online benefits today, and the possible risks and ...
(Date:5/6/2016)... ... 06, 2016 , ... Canadian author Mark Black is a speaker, author, and life ... around the world … with the help of his publisher Strategic Book Group and its ... in a hospital bed waiting for a miracle: He needed a heart and double-lung transplant. ...
(Date:5/6/2016)... ... May 06, 2016 , ... Multiple award winning ... and operated for over 35 years. Maintaining core values of exceptional customer service, quality ... and made them a leading name in San Diego plumbing, and other services including ...
(Date:5/6/2016)... ... May 06, 2016 , ... In honor of Military ... corporate training, and the National Military Family Association, a nonprofit that works to ... second full-tuition scholarship recipient of 2016. , “Being awarded this scholarship by ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... May 4, 2016  Compass Diversified Holdings (NYSE: ... an owner of leading middle market businesses, announced today ... March 31, 2016. First Quarter 2016 Highlights ... Reinvestment ("CAD" or "Cash Flow") of $13.6 million for ... loss of $15.0 million for the first quarter of ...
(Date:5/4/2016)... 4, 2016 According to market research ... Demand Forecast to 2022 - Industry Insights by Slice Type ... and Others)" by P&S Market Research, the global computed ... and it is expected to grow at a CAGR of ... type segment is expected to witness the faster growth, CAGR ...
(Date:5/4/2016)... DUBLIN , May 4, 2016 /PRNewswire/ ... the addition of the  "Global Multiple Myeloma ...  report to their offering.       ... Multiple Myeloma Market and Competitive Landscape Highlights ... pipeline products, Multiple Myeloma epidemiology, Multiple Myeloma ...
Breaking Medicine Technology: